Merck to seek EAU for experimental Covid-19 drug molnupiravir
Merck has been producing molnupiravir at risk. It expects to produce 10 million courses of treatment by the end of 2021
Merck has been producing molnupiravir at risk. It expects to produce 10 million courses of treatment by the end of 2021
0 Comments
Post a Comment